Doctor in Behavioral Sciences, coach-trainer and professional musician.

Eija is currently the CEO and co-founder of an awarded applied games start up called Altogame. Altogame is a game-changing virtual multiplayer environment for innovation, collaboration and training simulations.

Prior to founding Altogame, Eija developed an internationally unique face-to-face coaching method integrating musicians ́ professional top performance and well-being. She wrote the first Finnish coaching related doctoral thesis on the subject, and the first white paper on how to transform organizations by using arts-derived interventions. Eija has created and run programs on how to integrate agility, innovation and top performance in numerous organizations including Nokia, Kone, UCL, Aalto University, and Anglia-Ruskin University. She is very experienced as public speaker, coach and trainer. The first part of her professional career Eija was an internationally performing musician.

In regard to start-up scenes and communities, Eija has been a start-up member of numerous accelerators/hubs and participated various programs. She has herself acted as a mentor and delivered training to start-ups e.g. in Aalto University and University of the Arts Helsinki (Finland). In addition to the business subjects, her training has included also Human Factor themes such as working with customers (e.g. to understand the real problem), pitching to different audiences (e.g. from academic to corporate, customer or investor viewpoint and language), top performing (multi-cultural, cross-disciplinary etc.) teams, creativity at work, self-leadership, persuasion skills and performing under pressure.

Currently Eija is based in Cambridge, UK.

Bioinformatics scientist specialised in genome analysis with 15 years of experience in software development and project management. Fiona left her job at Illumina Cambridge in 2013 to pursue her vision of enabling efficient genomic data sharing and founded the charity DNAdigest. In August 2014 she founded Repositive as a spin out of DNADigest.

Keywords:
- social enterprise and social impact
- business model development
- software products
- selling to biopharma and CROs
- raising funding
- strategic partnerships

Katarzyna joined the IMED Oncology team at AstraZeneca as a Drug project Information Manager, taking responsibility for scientific information management governance. In this role Katarzyna oversees and aligns scientific communication strategies with the oncology business acumen.
Prior to this role, she worked for an emerging Clinical Research Organisation in Cambridgeshire, being accountable for clinical project management and cultivating relationships with key business partners. At Amgen, she conducted a business insight project to evaluate market share.

Katarzyna is passionate about oncology and neuroscience R&D, though encouraging open innovation knowledge transfer, scientific communications. Her area of interest lies in the new applications of AI technologies in Healthcare. For the past few years, she has enjoyed gaining experience working both with small businesses and start-ups in the UK, and also global organisations (the Alzheimer’s Society, WHO, and the United Nations internationally.

Katarzyna completed her MSc in Clinical Drug Development and Management at the Queen Mary University/UCL, focused on clinical research recruitment strategies. She holds a BSc degree in Biomedicine and an Eng. degree in Pharmaceutical Technology. As a part of the Erasmus exchange programme she collaborated with the Max Planck Institute for Innovation and Competition in Munich, and the Uppsala University where she focused on pharmaceutical IP innovation.

Dr Karolina Zapadka is a co-founder and Managing Director at ZapaBio Ltd, a global consulting company which aims to support Bioscience Innovation. Her interests lie in the life sciences and healthcare industry and the interface between business and science, entrepreneurship and technology transfer.

Karolina has a strong interest in knowledge exchange and in facilitating collaborations between Academia, Industry and Government. As such she joined the Oxbridge Biotech Roundtable (OBR) in 2013 as President of Cambridge Chapter, where she was highly involved in organising workshops and seminars, as well as setting up and marketing of the OneStart competition. For the past almost eight years she has been actively involved in Cambridge ecosystem, first working in an emerging biotech company (Arecor Ltd.), later during her PhD and postdoc in non-profit organisations. She is a founding member and a former Executive Team Member of Global Innovation Forum Ltd (IF), a global, interdisciplinary network of young researchers, industry
professionals and policy makers. Moreover, she participated in many entrepreneurship courses run by Cambridge Judge Business School including: BioInno Entrepreneurship Course in 2014, a Life Sciences Start-up Weekend with AstraZeneca in 2015, Accelerator Programme, Ignite 2016 & 2017.

She has over nine years of professional experience in research work in both academia and the industry. Her academic work includes a double research Master diploma from Jagiellonian (Poland) and Lund (Sweden) University, PhD from Cambridge (UK) and Postdoctoral work between University of Cambridge and MedImmune. Her research interests are focused on diabetes, drug discovery, stability and formulations of peptide pharmaceuticals.

Matthew specialises in the fields of electronics, mobile telecommunications, software and mechanical devices. He has experience in the drafting, filing and prosecution of patent applications in the UK, Europe, USA, Asia, and other jurisdictions across the world.

Having been awarded the prize of Young Electronic Designer of the Year Award in 2002, Matthew then went on to graduate from Leeds University with a first class Master’s Degree in Electronic Engineering. Matthew joined the patent profession in 2008 working for a London based firm of patent & trademark attorneys. Matthew qualified as a European Patent Attorney in 2012 and a UK Chartered Patent Attorney in 2013. He joined Marks & Clerk in 2015.

Mash-Hud is a qualified patent attorney who is experienced in drafting and prosecution work in semiconductor technologies, opto-electronics, mobile telecommunications, software, medical devices and oil well technology. He also has experience at opposition proceedings before the EPO.

After completing a BSc degree with first class honours in Electronics and Computing, Mash-Hud moved to the University of Cambridge where he gained an MPhil and PhD in Solid State Engineering. Mash-Hud's MPhil research was directed to modelling novel power devices for emerging technologies. He then carried out further research for his PhD on silicon-on-insulator (SOI) based high voltage devices for power ICs and nanoscale transistors using silicon nanowires.

Mash-Hud joined Marks & Clerk in 2008 and qualified as a European Patent Attorney and UK Chartered Patent Attorney in 2013. Mash-Hud has been recognised as a rising star by Managing Intellectual Property, IP Stars, 2017 and 2018.

Tony Hart is the Head of Smart Oxford, Oxford’s smart city project.

Tony has been working with technology innovation companies and start-ups across Oxfordshire and the UK for the past 15 years, having worked for and with major technology companies in the US, Europe, India and China. Recently he was the Managing Director of the UK subsidiary of Holley Technology, the leading Chinese smart meter manufacturer based in Hangzhou.

He has a strong focus and ability at identifying and bringing to market (commercialising) technology solutions within both corporate and entrepreneurial (start-up) environments.

Tony has an MA in Engineering & Economics from the University of Oxford and an MBA from Henley Management School.

Brian has had a long and successful career as medtech business leader in large corporations, AIM listed companies and early stage ventures. He was CEO of Lombard Medical Technologies (2005 – 2009) and General Manager of Boston Scientific in UK (1999 – 2005). Brian is currently a board member of three emerging medtech companies, including Oxford Endovascular.

Nick is an NHD Trust Digital Innovation & Population Health Lead, a startup entrepreneur and co-founder of health innovation lab. He has a background as a neurosurgeon with over 15 years of front line clinical experience in the NHS.

Marc is an economic sociologist in the Strategy, Innovation and Marketing Faculty at Saïd Business School and a Governing Body Fellow of Wolfson College. His teaching focuses on strategy and innovation, implementation, and entrepreneurial leadership and leadership for complex operations. At Oxford, he is Academic Director for the Science Innovation Plus initiative, support many student and research activities for the Skoll Centre for Social Entrepreneurship, and serve as a core faculty member for the Goldman Sachs 10K Women Entrepreneurs Programme in China. He is advisor/mentor to five startups founded by recent Oxford alumni, and a strategic advisor for Oxford Entrepreneurs, Global Thinkers Forum, Local Insight/Global Impact, and the Oxbridge Biotechnology Roundtable. He is recently supported an MBA team working with the World Economic Forum Global Agendas Councils. Marc does custom executive education with a range of global firms, public sector organisations, and civil society agencies.